Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.97)
# 88
Out of 5,022 analysts
654
Total ratings
58.6%
Success rate
37.5%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Reiterated: Buy | n/a | $4.59 | - | 46 | Oct 1, 2026 | |
| HROW Harrow | Reiterated: Buy | n/a | $30.48 | - | 46 | Sep 29, 2026 | |
| NRXS NeurAxis | Reiterated: Buy | n/a | $7.11 | - | 14 | Sep 29, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $12 | $9.08 | +32.16% | 31 | Sep 29, 2026 | |
| TELA TELA Bio | Initiated Coverage: Buy | $2 | $1.14 | +75.44% | 1 | Sep 25, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Hold | n/a | $1.55 | - | 31 | Sep 22, 2026 | |
| MDWD MediWound | Reiterated: Buy | n/a | $13.52 | - | 16 | Sep 22, 2026 | |
| INDV Indivior Pharmaceuticals | Reiterated: Buy | n/a | $35.71 | - | 39 | Sep 17, 2026 | |
| BFLY Butterfly Network | Reiterated: Buy | $10 | $8.95 | +11.73% | 25 | Sep 2, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $4 | $0.4066 | +883.77% | 3 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $178 → $173 | $72.10 | +139.94% | 29 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.07 | +93.24% | 20 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $9.10 | +86.81% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $76 | $55.36 | +37.28% | 39 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $10.20 | +76.47% | 34 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $0.6 | $0.3411 | +75.90% | 38 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $15.13 | +58.63% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $18 | $13.13 | +37.09% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.96 | +102.70% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.1 → $1.7 | $1.63 | +4.29% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $6.92 | +189.02% | 35 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.19 | +131.21% | 19 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.64 | - | 33 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.14 | - | 1 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.93 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.23 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.53 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $194.88 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $105.93 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.87 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $302.96 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.07 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.56 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $107.21 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.81 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $10.72 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.24 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $33.60 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $13.89 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.11 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.87 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.94 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.08 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $25.81 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $13.16 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $28.10 | n/a | 1 | May 3, 2023 |
MiMedx Group
Oct 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.59
Upside: -
Harrow
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.48
Upside: -
NeurAxis
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.11
Upside: -
Xeris Biopharma Holdings
Sep 29, 2026
Reiterated: Buy
Price Target: $12
Current: $9.08
Upside: +32.16%
TELA Bio
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $1.14
Upside: +75.44%
CVRx, Inc.
Sep 22, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.55
Upside: -
MediWound
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.52
Upside: -
Indivior Pharmaceuticals
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.71
Upside: -
Butterfly Network
Sep 2, 2026
Reiterated: Buy
Price Target: $10
Current: $8.95
Upside: +11.73%
Fractyl Health
Sep 2, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4066
Upside: +883.77%
Aug 18, 2026
Reiterated: Buy
Price Target: $178 → $173
Current: $72.10
Upside: +139.94%
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $2.07
Upside: +93.24%
Aug 14, 2026
Reiterated: Buy
Price Target: $17
Current: $9.10
Upside: +86.81%
Aug 14, 2026
Reiterated: Buy
Price Target: $62 → $76
Current: $55.36
Upside: +37.28%
Aug 12, 2026
Rated: Buy
Price Target: $18
Current: $10.20
Upside: +76.47%
Aug 12, 2026
Rated: Buy
Price Target: $0.6
Current: $0.3411
Upside: +75.90%
Aug 7, 2026
Reiterated: Buy
Price Target: $24
Current: $15.13
Upside: +58.63%
Aug 6, 2026
Rated: Buy
Price Target: $16 → $18
Current: $13.13
Upside: +37.09%
Aug 6, 2026
Reiterated: Buy
Price Target: $6
Current: $2.96
Upside: +102.70%
Aug 6, 2026
Reiterated: Buy
Price Target: $1.1 → $1.7
Current: $1.63
Upside: +4.29%
Jul 31, 2026
Rated: Buy
Price Target: $20
Current: $6.92
Upside: +189.02%
Jul 22, 2026
Reiterated: Buy
Price Target: $12
Current: $5.19
Upside: +131.21%
Jul 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.64
Upside: -
Jul 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.14
Upside: -
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.93
Upside: -
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.23
Upside: -
Nov 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $56.53
Upside: -
Nov 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $194.88
Upside: -
Oct 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $105.93
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $35.87
Upside: -
Oct 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $302.96
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $70.07
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $2.56
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: n/a
Current: $107.21
Upside: n/a
Jul 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.81
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $12
Current: $10.72
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.24
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $33.60
Upside: n/a
Aug 1, 2024
Reiterated: Buy
Price Target: $38
Current: $13.89
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $11.11
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $10
Current: $4.87
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $4.94
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $1.08
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $25.81
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $13.16
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $28.10
Upside: n/a